1809427-19-7
1809427-19-7
Chemical Structure
DT-061
- CAS No.: 1809427-19-7
- Formula:C25H23F3N2O5S
- Molecular Weight:520.52
IUPAC Name: N-((1R,2R,3S)-2-hydroxy-3-(10H-phenoxazin-10-yl)cyclohexyl)-4-(trifluoromethoxy)benzenesulfonamide
InChIKey: WGKGADVPRVLHHZ-ZHRMCQFGSA-N
SMILES: O=S(C1=CC=C(OC(F)(F)F)C=C1)(N[C@H]2[C@H](O)[C@@H](N3C4=C(C=CC=C4)OC5=CC=CC=C35)CCC2)=O
Biological Activity: DT-061 is an orally bioavailable activator of protein phosphatase 2A (PP2A) and could be applied in the therapy of KRAS-mutant and MYC-driven tumorigenesis[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
DT-061 | 99.83% | DT-061 is an orally bioavailable activator of protein phosphatase 2A (PP2A) and could be applied in the therapy of KRAS-mutant and MYC-driven tumorigenesis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
